Refining Physician Quality Indicators for Screening Mammography in Older Women: Distinguishing Appropriate Use from Overuse
Authors:
- 1 March 2013
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 61 (3) , 380-387
Abstract
Objectives: To assess the feasibility of refining physician quality indicators of screening mammography use based on patient life expectancy. Design: Retrospective population‐based cohort study. Setting: Texas. Participants: Three thousand five hundred ninety‐five usual care providers ( UCP s) with at least 10 female patients aged 67 and older on January 1, 2008, with an estimated life expectancy of 7 years or more (222,584 women) and at least 10 women with an estimated life expectancy of less than 7 years (90,903 women), based on age and comorbidity. Measurements: Screening mammography use in 2008–09 by each provider in each population. Results: The average adjusted mammography screening rates for UCP s were 31.1% for women with a life expectancy of less than 7 years and 55.2% for women with a life expectancy of 7 years or longer. For women with limited life expectancy, 3.7% of UCP s had significantly lower and 9.2% had significantly higher than average adjusted mammography screening rates. For women with longer life expectancy, 16.7% of UCP s had significantly lower and 19.7% had significantly higher than average rates. UCP adjusted screening rates were stable over time (2006–07 vs 2008–09, correlation coefficient ( r ) = 0.65, P < .001). There was a strong correlation between UCP screening rates for their female patients with a life expectancy of less than 7 years and 7 years or longer ( r = 0.67, P < .001). Most physician characteristics associated with higher screening rates (e.g., being female and foreign trained) in women with longer life expectancy were also associated with higher screening rates in women with limited life expectancy. Conclusion: Providers with high mammography screening rates for women with longer life expectancy also tend to screen women with limited life expectancy. Quality indicators for screening practice can be improved by distinguishing appropriate use from overuse based on patient life expectancy.Keywords
Funding Information
- Cancer Prevention Research Institute of Texas (RP101201)
- National Institutes of Health (K05CA134923, 8UL1TR000071, 5P30AG024832, 5P30AG024832-08)
This publication has 36 references indexed in Scilit:
- Integrating Age and Comorbidity to Assess Screening Mammography UtilizationAmerican Journal of Preventive Medicine, 2012
- The Central Role of Prognosis in Clinical Decision MakingJAMA, 2012
- Uninformed Compliance or Informed Choice? A Needed Shift in Our Approach to Cancer ScreeningJNCI: Journal of the National Cancer Institute, 2011
- Quality Indicators for Older AdultsJAMA, 2011
- Association Between Quality of Care and the Sociodemographic Composition of Physicians’ Patient Panels: A Repeat Cross-Sectional AnalysisJournal of General Internal Medicine, 2011
- Impact of Cognitive Impairment on Screening Mammography Use in Older US WomenAmerican Journal of Public Health, 2010
- Index to Predict 5-Year Mortality of Community-Dwelling Adults Aged 65 and Older Using Data from the National Health Interview SurveyJournal of General Internal Medicine, 2009
- Ambulatory Care Provided by Office-Based Specialists in the United StatesThe Annals of Family Medicine, 2009
- Physician Gender and Screening: Do Patient Differences Account for Differences in Mammography Use?Women & Health, 1997
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987